News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,323 Results
Type
Article (14230)
Company Profile (282)
Press Release (252811)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79521)
Career Advice (153)
Deals (13228)
Drug Delivery (35)
Drug Development (50454)
Employer Resources (31)
FDA (5723)
Job Trends (5131)
News (144424)
Policy (10035)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21657)
ALS (63)
Alzheimer's disease (842)
Antibody-drug conjugate (ADC) (89)
Approvals (5743)
Artificial intelligence (119)
Autoimmune disease (17)
Automation (5)
Bankruptcy (105)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (42)
Biotechnology (232)
Bladder cancer (47)
Brain cancer (20)
Breast cancer (146)
Cancer (1364)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (110)
Cell therapy (314)
Cervical cancer (8)
Clinical research (40984)
Collaboration (519)
Compensation (253)
Complete response letters (13)
COVID-19 (1034)
CRISPR (39)
C-suite (154)
Cystic fibrosis (76)
Data (1424)
Denatured (11)
Depression (29)
Diabetes (130)
Diagnostics (1294)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (82)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (88)
Earnings (29739)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48295)
Executive appointments (440)
FDA (6387)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (485)
Gene editing (93)
Generative AI (10)
Gene therapy (240)
GLP-1 (363)
Government (1079)
Grass and pollen (2)
Guidances (19)
Healthcare (6593)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (88)
Indications (18)
Infectious disease (1100)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (62)
Interviews (17)
IPO (7268)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (5)
Layoffs (205)
Leadership (3)
Legal (1386)
Liver cancer (31)
Lung cancer (194)
Lymphoma (89)
Machine learning (2)
Management (7)
Manufacturing (126)
MASH (50)
Medical device (2593)
Medtech (2594)
Mergers & acquisitions (6279)
Metabolic disorders (376)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (23)
Neuroscience (1233)
NextGen: Class of 2025 (2017)
Non-profit (852)
Northern California (1627)
Now hiring (22)
Obesity (191)
Opinion (102)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (53)
Parkinson's disease (119)
Partnered (8)
Patents (123)
Patient recruitment (69)
Peanut (35)
People (25591)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14475)
Phase II (19066)
Phase III (12055)
Pipeline (776)
Policy (43)
Postmarket research (852)
Preclinical (6079)
Press Release (30)
Prostate cancer (57)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (286)
Real estate (1418)
Recruiting (12)
Regulatory (8604)
Reports (15)
Research institute (939)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (57)
Series A (95)
Series B (60)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1431)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1972)
State (1)
Stomach cancer (4)
Supply chain (20)
Tariffs (5)
The Weekly (36)
United States (12675)
Vaccines (208)
Venture capitalists (30)
Weight loss (108)
Women's health (15)
Worklife (2)
Date
Today (15)
Last 7 days (257)
Last 30 days (1408)
Last 365 days (19569)
2025 (5478)
2024 (20554)
2023 (22414)
2022 (26822)
2021 (27806)
2020 (23358)
2019 (16225)
2018 (11742)
2017 (13747)
2016 (11839)
2015 (14350)
2014 (10395)
2013 (7486)
2012 (7533)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (41)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17251)
Australia (2928)
California (3689)
Canada (1098)
China (332)
Colorado (142)
Connecticut (147)
Delaware (93)
Europe (37135)
Florida (443)
Georgia (115)
Idaho (16)
Illinois (219)
India (10)
Indiana (91)
Iowa (1)
Japan (73)
Kansas (61)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (459)
Massachusetts (2917)
Michigan (70)
Minnesota (142)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (929)
New Mexico (12)
New York (997)
North Carolina (535)
North Dakota (4)
Northern California (1627)
Ohio (109)
Oklahoma (9)
Oregon (21)
Pennsylvania (699)
Puerto Rico (5)
Rhode Island (16)
South America (208)
South Carolina (4)
Southern California (1431)
Tennessee (25)
Texas (423)
Utah (50)
Virginia (74)
Washington D.C. (30)
Washington State (337)
Wisconsin (14)
267,323 Results for "seres therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 13, 2025
·
20 min read
Press Releases
Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025
March 5, 2025
·
2 min read
Press Releases
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
March 4, 2025
·
7 min read
Press Releases
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
November 22, 2024
·
1 min read
Press Releases
Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale
January 17, 2025
·
4 min read
Press Releases
Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference
December 16, 2024
·
5 min read
Deals
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science
Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced that it has entered into a non-binding memorandum of understanding with Nestlé Health Science for the sale of Seres’ VOWST assets that will provide Nestlé Health Science with full VOWST product and related intellectual property rights.
June 6, 2024
·
5 min read
Business
Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Seres Therapeutics, Inc., a leading microbiome therapeutics company, reported first quarter 2024 financial results and provided business updates.
May 8, 2024
·
13 min read
Genetown
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
Seres Therapeutics, Inc. announced today that Eric Shaff, President and Chief Executive Officer of Seres Therapeutics, will participate in a panel discussion at the Cowen 44th Annual Health Care Conference on Wednesday, March 6, 2024 at 9:10 a.m. ET.
February 27, 2024
·
1 min read
Genetown
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 07, 2024
Seres Therapeutics, Inc. announced that on June 5, 2024, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 6,188 shares of its common stock to one new employee, consisting of stock options to purchase 4,125 shares of common stock and restricted stock units covering 2,063 shares of its common stock.
June 7, 2024
·
1 min read
1 of 26,733
Next
